Publication | Open Access
P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia
38
Citations
62
References
2022
Year
Hematological MalignancyMedicineAcute Myeloid LeukemiaMixed-phenotype Acute LeukemiaMalignant Blood DisorderXpo1 InhibitionRadiation OncologyP2ry2-akt ActivationCell BiologyCell SignalingCancer ResearchMyeloid Neoplasia
| Year | Citations | |
|---|---|---|
Page 1
Page 1